4 Results for "

TFCP2L1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "TFCP2L1" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-12834A
CAS No.: 1314118-94-9
Purity:  98.24%
Target:  

MAPKAPK2 (MK2) HSP

Research Areas:  

Cancer

MK2-IN-1 hydrochloride (compound 1) is a potent and selecitve MAPKAPK2 (MK2) inhibitor with an IC50 of 0.11 uM for MK2 and an EC50 of 0.35 uM for pHSP27. MK2-IN-1 hydrochloride impaires the phosphorylation level of serine residues in the Tfcp2l1 protein .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-12834
CAS No.: 1314118-92-7
Purity:  99.04%
Target:  

MAPKAPK2 (MK2) HSP

Research Areas:  

Cancer

MK2-IN-1 (compound 1) is a potent and selecitve MAPKAPK2 (MK2) inhibitor with an IC50 of 0.11 uM for MK2 and an EC50 of 0.35 uM for pHSP27. MK2-IN-1 impaires the phosphorylation level of serine residues in the Tfcp2l1 protein .
loading...
    loading...
Cat. No.: HY-162934
CAS No.: 364621-46-5
Research Areas:  

Cancer

TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1’s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib (HY-10201) to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells .
loading...
    loading...
Cat. No.: HY-RS14416
Research Areas:  

Others

TFCP2L1 Human Pre-designed siRNA Set A contains three designed siRNAs for TFCP2L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...